Full Breakdown
ZetrOZ Systems Introduces Wearable Ultrasound Technology to Enhance Recovery in Major League Baseball
2/26/2026, 2:35:04 PM
Overview of ZetrOZ's Technology and Its Relevance to MLB
As Major League Baseball (MLB) teams prepare for spring training, ZetrOZ Systems is introducing its sustained acoustic medicine (sam®) wearable ultrasound device, aimed at addressing the increasing prevalence of injuries among players. The device is designed to accelerate recovery from common soft-tissue injuries, including UCL tears, hamstring pulls, and oblique strains, which have seen a notable rise in recent years. A 2024 MLB study reported 41 UCL surgeries for major league players and 240 for minor league players, indicating a significant concern for team health as they enter the season.
The Mechanism Behind sam® Technology
The sam® device operates by generating warmth deep within soft tissues, which enhances blood flow and facilitates the delivery of oxygenated hemoglobin. This process aids in the removal of cytokine enzymes and cellular waste, thereby reducing pain and inflammation, improving function and range of motion, and shortening recovery times. The effectiveness of this technology is supported by over 20 clinical studies and more than 40 peer-reviewed journal articles.
Official Statements & Responses
Dr. George K. Lewis, founder and CEO of ZetrOZ Systems, emphasized the importance of the sam® device during spring training, stating, “Our sam® wearable ultrasound technology provides athletes with a clinically proven way to accelerate recovery and optimize performance.” He expressed hope that by collaborating with teams, ZetrOZ can help maintain player health throughout the season.
Criticism & Opposition
While the introduction of the sam® device is met with optimism, some skepticism exists regarding its widespread adoption. Critics question whether the technology can effectively integrate into the rigorous schedules of professional athletes, particularly during the demanding spring training period. Additionally, concerns about the long-term efficacy of wearable devices in preventing injuries remain a topic of debate among sports medicine professionals.
Broader Implications for Player Health
The introduction of the sam® device comes at a crucial time when MLB teams are increasingly focused on injury prevention and player health management. The device's FDA clearance for daily home use allows athletes to incorporate therapy seamlessly into their routines, potentially reducing reliance on invasive treatments and addictive pain medications. As teams look to optimize player performance and minimize injury risks, the sam® technology could play a pivotal role in shaping recovery protocols in professional baseball.
What's Next for ZetrOZ Systems
ZetrOZ Systems plans to engage with various MLB teams during spring training to demonstrate the capabilities of the sam® device. The company aims to establish partnerships that could lead to broader adoption of its technology across the league, ultimately contributing to improved player health and performance as the season progresses.
In summary, ZetrOZ Systems' sam® wearable ultrasound technology represents a significant advancement in sports medicine, offering a promising solution to the challenges of injury recovery in Major League Baseball.
